Common Injection Sites Abdomen: Around the navel area, avoiding the immediate vicinity of the belly button
No Human GH Stimulation Trials Unlike CJC-1295 with DAC, which has a published Phase I/II human pharmacokinetic study directly measuring GH and IGF-1 responses, this compound does not have equivalent published human data for its GH-stimulating effects
10.1152/ajpheart.00996.2010 153
When the applicator is positioned over the treatment area, it pulls your skin into the handpiece
Apply sunscreen during the day for added protection
By this point, users typically see: 8-15 pounds fat loss (highly variable based on starting point, diet, and training) Significant improvement in body composition Reduced waist circumference (often 2-4 inches) Better muscle definition Improved energy and recovery Enhanced metabolic efficiency (easier to maintain leanness) The fat loss is real and maintainable